已收盤 05-29 16:00:00 美东时间
+0.310
+1.35%
今日重点评级关注:康托·菲茨杰拉德:维持Ultragenyx药业"超配"评级,目标价从84美元升至96美元;Ascendiant Capital:维持Liqtech国际"买入"评级,目标价从4.3美元升至4.4美元
05-22 10:18
Barclays analyst Matthew Bouley maintains James Hardie Industries (NYSE:JHX) with a Equal-Weight and lowers the price target from $22 to $21.
05-21 23:07
James Hardie Industries (NYSE:JHX) released fourth-quarter financial results an...
05-20 13:55
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据James Hardie业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **第四季度业绩:** - 营收:14亿美元,同比增长45%(主要由AZEK收购驱动),有机净销售额下降1% - 调整后EBITDA:3.81亿美元,调整后EBITDA利润率为27.1% - 调整后净利润:1.73亿美元 - 调整后每股收益:0.30美元 **全年业绩:** - 营收:48亿美元,同比增长25%,有机净销售额下降2% - 调整后EBITDA:12.7亿美元,调整后EBITDA利润率为26.2% - 自由现金流:3.14亿美元(包括第三季度澳大利亚土
05-20 12:02
Pershing Square Inc.涨4.09%;Roblox Corp. Class A涨3.26%;HF Sinclair Corporation涨3.04%
05-20 06:10
华盛资讯5月20日讯,詹姆斯哈迪公布2026财年年度业绩,公司年度营收48.36亿美元,同比增长24.7%,归母净利润1.04亿美元,同比下滑75.5%。
05-20 05:32
华盛资讯5月20日讯,詹姆斯哈迪公布2026财年Q1业绩,公司Q1营收14.04亿美元,同比增长44.5%,归母净利润0.29亿美元,同比下滑34.6%。
05-20 05:19
James Hardie Industries (NYSE:JHX) sees FY2027 sales of $5.250 billion-$5.410 billion vs $5.518 billion analyst estimate.
05-20 04:32
James Hardie Industries (NYSE:JHX) sees Q1 sales of $1.320 billion-$1.350 billion vs $1.396 billion analyst estimate.
05-20 04:32
James Hardie Industries (NYSE:JHX) reported quarterly earnings of $0.30 per share which beat the analyst consensus estimate of $0.29 by 3.45 percent. This is a 16.67 percent decrease over earnings of $0.36 per share from
05-20 04:31